Taken together, we hypothesize that PRMT5 overexpression can promote the cancer phenotype through PRMT5-mediated NF-κB activation, whereas using PR5-LL-CM01 to block this activity could impede PDAC and CRC progression (Figure 7E). Here, NFKB1 is linked to colorectal carcinoma.